Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Parnell Pharmaceuticals Holdings - 11 Year Stock Split History | PARNF

Stock split history for Parnell Pharmaceuticals Holdings since 2014. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
  
Parnell Pharmaceuticals Holdings Annual Stock Splits
Parnell Pharmaceuticals Holdings Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $0.000B
Parnell Pharmaceuticals Holdings Ltd. is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing animal health solutions. It manufactures and markets cattle reproduction, cattle mastitis, anesthetics, laminitis treatment, and orthopedic treatment products. The Company operates in four segments: Companion Animal, Production Animal-Unites States, and Production Animal-rest of the world and Manufacturing Operations. ZYDAX (R), GLYDE (R) and TERGIVE (R) are Parnell's premium osteoarthritis product suite. Parnell Pharmaceuticals Holdings Ltd. is headquartered in Alexandria, Australia.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.797B 7.07
Dr Reddy's Laboratories (RDY) India $12.305B 22.33
BridgeBio Pharma (BBIO) United States $6.733B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.787B 14.51
Bausch Health Cos (BHC) Canada $1.638B 1.19
Amphastar Pharmaceuticals (AMPH) United States $1.196B 8.03
Taysha Gene Therapies (TSHA) United States $0.598B 0.00
Personalis (PSNL) United States $0.427B 0.00
Assembly Biosciences (ASMB) United States $0.118B 0.00
Sol-Gel Technologies (SLGL) Israel $0.020B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00